This is a study to evaluate non-invasive procedures for patients diagnosed as Central Serous Chorioretinopathy
Not Applicable
Completed
- Registration Number
- CTRI/2018/04/013205
- Lead Sponsor
- Giridhar Eye Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
All cases acute or chronic with active Central Serous Chorioretinopathy
Exclusion Criteria
Patients with polipoidal choroidal vasculopathy, age related macular diseases and any other inflammatory pathology.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To report the exact location of multiple yellowish dot-like precipitates in Central Serous Chorioretinopathy.Timepoint: To report the exact location of multiple yellowish dot-like precipitates in Central Serous Chorioretinopathy.
- Secondary Outcome Measures
Name Time Method A detailed protocol will be used to obtain significant history to assess various risk factors contributing to CSC affected eye recorded by Enhanced Depth Imaging Optical Coherence Tomography.Timepoint: 12 Months